Oscar Franklin Smith is scheduled to die by a new lethal injection protocol for the 1989 murders of his estranged wife and ...

A twice-yearly injection of Sunlenca (lenacapavir) reduces the risk of HIV infection by 96%, which is significantly more effective than oral pre-exposure prophylaxis (PrEP) using pills like ...

Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access? By Ernie Mundell HealthDay Reporter THURSDAY, Sept. 12, 2024 (HealthDay News) -- It could be a real breakthrough for people ...

However, results from a recent Gilead-funded clinical trial (Purpose-2) led by physicians at Emory University and Grady Health System indicate that a twice-yearly injection of Lenacapavir offers a 96% ...

Twice-yearly shots used to treat AIDS were 100% effective in preventing new infections in women, according to study results published Wednesday. There were no infections in the young women and ...

A large clinical trial in South Africa and Uganda has shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial ...

July 24, 2024 – A twice-yearly injection to prevent HIV could dramatically alter the course of an epidemic that has lead to the deaths of more than 40 million people since the 1980s. Twice ...

Twice-Yearly Injection 96% Effective in Preventing HIV Infection By Dennis Thompson HealthDay Reporter THURSDAY, Nov. 28, 2024 (HealthDay News) -- People whose partners have HIV must remember to ...